These potential effects are mild compared to the common side effects of prescription GLP-1 medications, which include constipation , nausea, vomiting, headaches , fatigue , anxiety , and muscle pain
No retatrutide-specific population PK by body weight
They produce 15-21% body weight reduction over 72 weeks
Non-peptide agonists like geniposide show oral bioavailability, broadening therapeutic potential [33]
Both medications are very effective at controlling blood sugar levels and aiding in weight loss, with retatrutide showing a small advantage in trials, but semaglutide has more long-term data as its already been FDA-approved
Individuals taking medications or with certain medical conditions: Some ingredients in Grns may interact poorly with various medications or medical conditions